Categories | Inventors

Aptamer-siRNA Chimera Targeting RORgammat in Th17 Cells for Topical Therapy of Psoriasis

 

OHSU # 1896

Technology Overview:

Researchers at Oregon Health & Science University and at the Portland VA Medical Center have discovered and validated a novel aptamer-siRNA chimera targeting RORgammat in Th17 cells for topical treatment of psoriasis. If interested in learning more, please contact the Office of Technology Transfer and Business Development (techmgmt@ohsu.edu) and reference Tech Id No. 1896.

Inventors:

Patents:

PublishedUnited StatesUS2017/0253879

Other Patents Filed

Categories:

For more information, contact:

Travis Cook
Senior Technology Development Manager
503-494-3229